Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy, while ...

Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day. Subscribe for FREE Patients exploring weight-loss management strategies may elect ...

Big compounders will have until May 22 to stop producing and dispensing compounded semaglutide, while smaller, state-run ...

Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!

An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval for ...

Sheu and colleagues additionally found that patients in the semaglutide group exhibited similar median HbA1c levels as controls before surgery (5.8% vs. 6%) and 1 year after surgery (5.5% vs.

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

There are also patients who chose to take semaglutide before having weight loss surgery ... studies that have found that taking semaglutide after surgery can further help patients lose weight ...

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...